Cannell Capital’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14,666	Closed	-$30.8K	–	82
2023 Q1	$30.8K	Hold	14,666	–	–	0.01%	80
2022 Q4	$22.7K	Hold	14,666	–	–	﹤0.01%	86
2022 Q3	$45K	Buy	14,666 +11,012	+301%	+$33.8K	0.01%	70
2022 Q2	$11K	Buy	+3,654	New	+$11K	﹤0.01%	78